NKMAX Co., Ltd.
Develops NK cell-based therapies, diagnostics, and biological products.
182400 | KO
Overview
Corporate Details
- ISIN(s):
- KR7182400002
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 분당구 돌마로 172 정자동, 헬스케어혁신파크 1층및6층, 성남시
- Website:
- https://nkmax.com/
- Sector:
- Manufacturing
Description
NKMAX Co., Ltd. is a biotechnology company focused on developing immune-based solutions centered on Natural Killer (NK) cells. The company's primary focus is the development of adoptive cell therapies to treat incurable diseases, including cancer, autoimmune disorders, and neurodegenerative conditions. Its portfolio includes anti-cancer immunotherapy treatments and other biological products. In addition to therapeutics, NKMAX develops and markets a precision diagnostic test that measures NK cell activity. The company also manufactures and supplies specialized reagents, such as high-quality recombinant proteins and antibodies, for biotechnology research, as well as a line of health functional foods designed to support the immune system.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-03-12 00:00 |
주주총회소집공고
|
Korean | 173.6 KB | ||
| 2020-03-12 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 12.0 KB | ||
| 2020-03-12 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.4 KB | ||
| 2020-02-21 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 120.0 KB | ||
| 2020-02-19 00:00 |
조회공시요구(풍문또는보도)(전환사채 발행 추진설)
|
Korean | 3.5 KB | ||
| 2020-02-19 00:00 |
조회공시요구(풍문또는보도)에대한답변(미확정)
|
Korean | 5.1 KB | ||
| 2020-02-14 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 23.5 KB | ||
| 2020-02-13 00:00 |
기업설명회(IR)개최
|
Korean | 8.2 KB | ||
| 2020-02-12 00:00 |
투자판단관련주요경영사항(NK세포 치료제 특허 관련 기술 이전 계약)
|
Korean | 7.9 KB | ||
| 2020-02-07 00:00 |
단일판매ㆍ공급계약체결
|
Korean | 9.9 KB | ||
| 2020-01-29 00:00 |
기타경영사항(특허권취득)(자율공시)(자연살해세포의 생산방법 및 항암용 조성물)
|
Korean | 5.5 KB | ||
| 2020-01-10 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 65.8 KB | ||
| 2019-12-30 00:00 |
전환사채(해외전환사채포함)발행후만기전사채취득(제6회차)
|
Korean | 13.3 KB | ||
| 2019-12-30 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 119.0 KB | ||
| 2019-12-18 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 118.9 KB |
Automate Your Workflow. Get a real-time feed of all NKMAX Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for NKMAX Co., Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for NKMAX Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
